+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Protein Drugs"

From
From
From
From
From
From
From
From
From
Bioengineered Protein Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Bioengineered Protein Drugs Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 190 Pages
  • Global
From
PEGylated Proteins Market - Global Forecast 2025-2032 - Product Thumbnail Image

PEGylated Proteins Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 182 Pages
  • Global
From
Cancer Biologics Market - Global Forecast 2025-2032 - Product Thumbnail Image

Cancer Biologics Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 191 Pages
  • Global
From
Orphan Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Orphan Drugs Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 180 Pages
  • Global
From
From
Loading Indicator

The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein. The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more